Blue Spark Technologies Introduces VitalTraq for Remote Vital Signs Monitoring

Revolutionizing Remote Patient Monitoring with AI and Contactless Technology

On January 25, 2024, Blue Spark Technologies, an innovator in clinical-grade wearable and digital health solutions, announced the release of VitalTraq™, a cutting-edge remote patient monitoring platform. This multi-sensor solution makes use of Remote Photoplethysmography (rPPG) technology, allowing for vital signs like Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate to be measured in a contactless manner through a simple facial scan.

Developed to upgrade the quality of continuous remote health care, VitalTraq offers an integrated system that combines the use of Blue Spark’s TempTraq® core body temperature sensor with the breakthrough rPPG facial scanning technology in one seamless mobile application. This arrangement not only simplifies the care process for patients but also alleviates logistical burdens for health care providers by reducing the number of devices needed.

John Gannon, President and CEO, emphasized that VitalTraq is particularly beneficial for remote patient monitoring during clinical trials and for post-operative patients at risk of complications. The platform’s continuous temperature monitoring feature has the potential to detect fevers faster, setting a new benchmark for vital signs monitoring and improving patient care through real-time insights.

The components of VitalTraq include mobile applications for iOS and Android, the HIPAA-compliant VitalTraq Connect cloud service (hosted on Google Cloud Platform), and a web-based clinical dashboard for remote monitoring. The platform is currently under examination by leading health care and pharmaceutical organizations, while the rPPG sensing technology is available for investigative use.

Dr. MaryAnne Rizk, a member of the advisory board for Blue Spark and an executive member of the Forbes Tech Council, praised VitalTraq’s intelligent design. The platform not only facilitates the decentralized health care journey for patients but also bestows clinical and consumer collaborators with objective real-world data, which is valuable for evidence generation strategies. Further, it assists health care providers in gaining deeper insights into patients’ responses to treatments.

Additionally, Blue Spark Technologies offers the FDA cleared TempTraq, a Bluetooth-enabled, single-use patch that provides continuous temperature monitoring with real-time alerts for temperature changes. This disposable patch is recognized as an FDA and CE Cleared Class II medical device, elevating the standard of care for temperature measurement in various clinical settings.

Blue Spark Technologies will showcase the VitalTraq platform at the SCOPE 2024 conference. The company, headquartered in Westlake, Ohio, focuses on pioneering continuous monitoring solutions that enhance patient care. Known for products such as TempTraq® and VitalTraq™, Blue Spark Technologies has a significant role in transforming how vital signs are monitored globally. They are also members of DiME, CancerX, and the Medidata Sensor Cloud Network.

To learn more about Blue Spark Technologies and their solutions, please visit their official website.

For media inquiries, Linda Kelley, a PR Consultant, can be contacted at 404-725-7117 or via email at linda.kelleypr(at)gmail.com.